'Plaintiffs & Defendants (Amgen, Horizon Therapeutics) requesting the court schedules a telephonic preliminary pre-trial/status conference during week of Aug 28 to address issues concerning scheduling & presentation of evidence'
Portfolio Pulse from Happy Mohamed
Amgen and Horizon Therapeutics have requested the court to schedule a telephonic preliminary pre-trial/status conference during the week of August 28 to address issues concerning scheduling and presentation of evidence.
August 25, 2023 | 7:57 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Amgen is involved in a legal case and has requested a preliminary pre-trial/status conference.
The news is about a legal case involving Amgen. However, the outcome of the case and its potential impact on the company's stock price is uncertain at this stage.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50
NEUTRAL IMPACT
Horizon Therapeutics is involved in a legal case and has requested a preliminary pre-trial/status conference.
The news is about a legal case involving Horizon Therapeutics. However, the outcome of the case and its potential impact on the company's stock price is uncertain at this stage.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50